181 related articles for article (PubMed ID: 17611586)
1. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
2. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.
Desmaris N; Bosch A; Salaün C; Petit C; Prévost MC; Tordo N; Perrin P; Schwartz O; de Rocquigny H; Heard JM
Mol Ther; 2001 Aug; 4(2):149-56. PubMed ID: 11482987
[TBL] [Abstract][Full Text] [Related]
3. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.
Nègre D; Mangeot PE; Duisit G; Blanchard S; Vidalain PO; Leissner P; Winter AJ; Rabourdin-Combe C; Mehtali M; Moullier P; Darlix JL; Cosset FL
Gene Ther; 2000 Oct; 7(19):1613-23. PubMed ID: 11083469
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts.
Arai T; Takada M; Ui M; Iba H
Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J
Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094
[TBL] [Abstract][Full Text] [Related]
6. High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction.
Yu H; Eton D; Wang Y; Kumar SR; Tang L; Terramani TT; Benedict C; Hung G; Anderson WF
Gene Ther; 1999 Nov; 6(11):1876-83. PubMed ID: 10602383
[TBL] [Abstract][Full Text] [Related]
7. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
Kafri T; Blömer U; Peterson DA; Gage FH; Verma IM
Nat Genet; 1997 Nov; 17(3):314-7. PubMed ID: 9354796
[TBL] [Abstract][Full Text] [Related]
8. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
[TBL] [Abstract][Full Text] [Related]
9. Production and concentration of pseudotyped HIV-1-based gene transfer vectors.
Reiser J
Gene Ther; 2000 Jun; 7(11):910-3. PubMed ID: 10849549
[TBL] [Abstract][Full Text] [Related]
10. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
[TBL] [Abstract][Full Text] [Related]
11. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells.
Indraccolo S; Minuzzo S; Feroli F; Mammano F; Calderazzo F; Chieco-Bianchi L; Amadori A
Gene Ther; 1998 Feb; 5(2):209-17. PubMed ID: 9578840
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.
Costello E; Munoz M; Buetti E; Meylan PR; Diggelmann H; Thali M
Gene Ther; 2000 Apr; 7(7):596-604. PubMed ID: 10819575
[TBL] [Abstract][Full Text] [Related]
13. Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors.
Barrette S; Douglas J; Orlic D; Anderson SM; Seidel NE; Miller AD; Bodine DM
Mol Ther; 2000 Apr; 1(4):330-8. PubMed ID: 10933951
[TBL] [Abstract][Full Text] [Related]
14. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Bartz SR; Vodicka MA
Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
[TBL] [Abstract][Full Text] [Related]
15. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.
Curran MA; Kaiser SM; Achacoso PL; Nolan GP
Mol Ther; 2000 Jan; 1(1):31-8. PubMed ID: 10933909
[TBL] [Abstract][Full Text] [Related]
16. Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells.
Kalajzic I; Stover ML; Liu P; Kalajzic Z; Rowe DW; Lichtler AC
Virology; 2001 May; 284(1):37-45. PubMed ID: 11352666
[TBL] [Abstract][Full Text] [Related]
17. Generation of replication-defective helper-free vectors based on simian immunodeficiency virus.
Kim SS; Kothari N; You XJ; Robinson WE; Schnell T; Uberla K; Fan H
Virology; 2001 Mar; 282(1):154-67. PubMed ID: 11259198
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analyses of stability of simple and complex retroviral vectors.
Higashikawa F; Chang L
Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826
[TBL] [Abstract][Full Text] [Related]
19. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo.
Johnson LG; Olsen JC; Naldini L; Boucher RC
Gene Ther; 2000 Apr; 7(7):568-74. PubMed ID: 10819571
[TBL] [Abstract][Full Text] [Related]
20. [Gene therapy of neurological diseases].
Kahn A; Haase G; Akli S; Guidotti JE
C R Seances Soc Biol Fil; 1996; 190(1):9-11. PubMed ID: 8881264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
